药石科技
(300725)
| 流通市值：51.38亿 | | | 总市值：60.90亿 |
| 流通股本：1.68亿 | | | 总股本：2.00亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,291,461,856.48 | 844,058,257.07 | 383,440,937.44 | 1,594,699,978.41 |
| 营业收入 | 1,291,461,856.48 | 844,058,257.07 | 383,440,937.44 | 1,594,699,978.41 |
| 二、营业总成本 | 1,089,728,764.88 | 705,562,849.81 | 344,985,836.29 | 1,296,321,446.2 |
| 营业成本 | 737,710,733.45 | 475,390,933.61 | 209,989,337.45 | 869,498,413.4 |
| 税金及附加 | 9,827,456.02 | 7,240,481.49 | 3,311,008.06 | 11,889,012.45 |
| 销售费用 | 41,155,552.09 | 27,093,765.77 | 13,061,252 | 40,955,832.97 |
| 管理费用 | 148,753,262.64 | 100,879,023.6 | 49,332,024.67 | 207,529,336.39 |
| 研发费用 | 132,533,134.98 | 92,468,805.87 | 48,393,224.73 | 168,323,636.98 |
| 财务费用 | 19,748,625.7 | 2,489,839.47 | 20,898,989.38 | -1,874,785.99 |
| 其中:利息费用 | 49,353,765.16 | 32,225,393.71 | 15,621,264.56 | 45,721,478.22 |
| 其中:利息收入 | 19,827,500.17 | 8,502,297.82 | 4,245,070.09 | 14,062,929.55 |
| 加:公允价值变动收益 | -55,717,490.98 | -41,579,248.22 | 8,300,210 | 1,986,347.04 |
| 加:投资收益 | 19,891,646.78 | 16,981,528.91 | 7,281,240.04 | 12,633,800.49 |
| 资产处置收益 | -108,152.76 | - | - | - |
| 资产减值损失(新) | -21,077,163.2 | -20,584,518.67 | -1,178,225.34 | -9,212,045.54 |
| 信用减值损失(新) | -6,785,212.05 | -2,554,427.26 | -1,914,510.76 | -7,081,019.85 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 137,936,719.39 | 90,758,742.02 | 50,943,815.09 | 296,705,614.35 |
| 加:营业外收入 | 32,501,420.54 | 30,334,956.18 | 3,178,705.47 | 31,531,936.82 |
| 减:营业外支出 | 300,229.95 | 212,921.34 | 62,017.47 | 4,974,174.33 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 170,137,909.98 | 120,880,776.86 | 54,060,503.09 | 323,263,376.84 |
| 减:所得税费用 | 16,091,654.73 | 6,989,792 | -3,695,458.35 | -2,627,481.8 |
| 六、净利润 | 154,046,255.25 | 113,890,984.86 | 57,755,961.44 | 325,890,858.64 |
| 持续经营净利润 | 154,046,255.25 | 113,890,984.86 | 57,755,961.44 | 325,890,858.64 |
| 归属于母公司股东的净利润 | 154,046,269.72 | 113,890,999.33 | 57,755,969.84 | 314,223,824.02 |
| 少数股东损益 | -14.47 | -14.47 | -8.4 | 11,667,034.62 |
| (一)基本每股收益 | 0.77 | 0.57 | 0.29 | 1.58 |
| (二)稀释每股收益 | 0.77 | 0.57 | 0.29 | 1.57 |
| 八、其他综合收益 | 2,855,135.08 | 3,876,953.12 | -1,249,965.96 | -1,425,964.94 |
| 归属于母公司股东的其他综合收益 | 2,855,135.08 | 3,876,953.12 | -1,249,965.96 | -1,425,964.94 |
| 九、综合收益总额 | 156,901,390.33 | 117,767,937.98 | 56,505,995.48 | 324,464,893.7 |
| 归属于母公司股东的综合收益总额 | 156,901,404.8 | 117,767,952.45 | 56,506,003.88 | 312,797,859.08 |
| 归属于少数股东的综合收益总额 | -14.47 | -14.47 | -8.4 | 11,667,034.62 |
| 公告日期 | 2023-10-31 | 2023-08-15 | 2023-04-22 | 2023-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |